Banks Get Hit… Plus Lawmakers Target Chinese Biotechs 9/10/24

10 Sep 2024 · 44 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Podcast Episode Notes: CNBC's "Fast Money" - Banks Get Hit… Plus Lawmakers Target Chinese Biotechs (9/10/24)

Episode Summary In this episode of "Fast Money," hosted by Melissa Lee, the panel discusses recent significant declines in major banking stocks, particularly JPMorgan, and the implications of these movements on the broader economy. The episode also delves into the Biosecure Act passed by lawmakers, which targets Chinese biotech firms and its potential impacts on drug prices and US-China relations.

---

Key Topics Discussed

  1. Banking Sector Under Pressure
  2. JPMorgan's Decline: The stock saw a downturn of up to 7.5% following President Daniel Pinto's comments on lower-than-expected net interest income for 2025.
  3. Other Banks' Outlooks:
  4. Goldman Sachs predicts a 10% drop in trading revenues.
  5. Citi's CFO warns of a potential consumer credit crunch.
  6. Bank of America reflects a mixed outlook for the upcoming quarter.
  • Market Implications: The panel discusses whether the banking warnings indicate a broader economic slowdown, with a consensus that caution should be exercised.
  1. Analysis of Bank Performance
  2. Investor Reactions:
  3. Karen Feinerman suggests the market reaction to JPMorgan's news might be excessive, indicating an overreaction in the context of broader stock performance.
  4. The importance of understanding capital requirements for investment banks is highlighted.
  • Technical Concerns: Guy Adami points out that the banking index (BKX) shows signs of concern, with historical price levels being reached.
  1. Credit Challenges and Consumer Impact
  2. Ally Financial: Shares plummeted 17% following warnings about increasing credit challenges, particularly in auto loans.
  3. Broader Economic Concerns: Discussions include potential cascading effects in the credit market, especially for lower-income households.
  1. Upcoming Economic Data
  2. CPI Report: Anticipation builds around the Consumer Price Index (CPI) data set to release the next day, seen as critical before the Federal Reserve meeting regarding interest rates.
  3. Market Expectations:
  4. Michael Schumacher from Wells Fargo discusses inflation expectations and the potential for 25 basis point interest rate cuts by the Fed.
  1. Legislation on Chinese Biotechs
  2. Biosecure Act: The House passes legislation aimed at restricting business with Chinese biotech firms, which could affect drug pricing as U.S. companies reassess partnerships.
  3. Bipartisan Concerns: The legislation has garnered strong bipartisan support, indicating a significant shift in how U.S. lawmakers view economic partnerships with China.

---

Key Takeaways

  • The banking sector is experiencing significant turmoil, with major institutions warning of lower future earnings.
  • Analyst sentiment reflects a cautious outlook for the American economy, particularly regarding consumer credit and spending behaviors.
  • Upcoming economic indicators, specifically the CPI, will be pivotal in shaping investor sentiment and Federal Reserve policy.
  • Legislative moves against Chinese firms could lead to increased domestic drug prices and a reevaluation of supply chains in the biotech sector.

---

Panelist Insights

  • Karen Feinerman: Cautiously optimistic about the banks, pointing to long-term potential despite immediate challenges.
  • Guy Adami: Emphasizes technical analysis and historical performance as critical indicators of market health.
  • Dan Nathan: Expresses skepticism about the market's ability to absorb bad news from banks and credit challenges effectively.
  • Julie Beal: Advocates for smaller boutique investment banks as more appealing, given the current environment.

---

Conclusion The episode presents a complex picture of the current financial landscape, with banking sector woes and geopolitical tensions influencing investor sentiment. Upcoming economic data and legislative changes signal potential volatility ahead. The panel urges careful consideration of market conditions while highlighting opportunities in niche investment areas.

---

Additional Notes

  • Future episodes will continue to monitor the developments in banking, consumer credit, and geopolitical relations, particularly with China.
  • The next broadcast will delve deeper into the implications of the CPI report and what it means for the Fed’s next moves on interest rates.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:02Live from the Nasdaq market and in the heart of New York City's Times Square this is fast money Here's what's on tap tonight. A bank breakdown from money centers to regionals to lenders, the warnings that sent these stocks tumbling today, and how you can trade the moves. Plus, we're counting down to tomorrow's big CPI print, the last big data point before the Fed is expected to cut rates. What tomorrow's number could mean for the central bank. And on the brink, WNBA star Cameron Brink joins us live from Gameplan in L.A. What she says is driving a surge in interest in the league and how she's looking to build her brand.

0:33I'm Melissa Lee, coming to you live from Studio B at the NASDAQ on the desk tonight. Karen Feinerman, Julie Beal, Guy Adami, and Dan Nathan. Look, Julie Beal's in the house. In the house. Nice. But we start off with big trouble in the big banks. J.P. Morgan falling as much as 7.5 percent at its lows after its president, Daniel Pinto, said he expects 2025 net interest income to come in below expectations. Pinto joins a chorus of bank execs tempering outlooks just yesterday. Goldman Sachs CEO David Solomon said he expects trading revenues to fall by 10 percent in the third quarter, while Citi's CFO warned of a consumer credit crunch.

1:06And just this afternoon, Bank of America CEO Brian Moynihan told her Sarah Eisen he expects mixed results in the upcoming quarter. Our trading revenue is sort of, we think it'll be up low single digits. That's kind of counter to what we've heard. And humans had down 10 percent. Yeah. In our investment banking revenue, I think it'll be softer because our mix of business in this quarter won't be strong. And check out shares of Ally Financial dropping over 17 percent after the company said credit challenges are increasing, particularly around auto loans. So are the banks sending signals that a true slowdown is here?

1:43There's a lot to unpack, but I turn to you for J.P. Morgan banks. So, J.P. Morgan, you know, my gut reaction seeing the stock down$16 was, wow, this is probably overdone. And it rallied a little. And I thought, all right, let me just actually listen to exactly what he said. And anyone can do that. You just go on JPMorgan Investor Relations. Even if you weren't at that conference, they put it on. So just a little PSA there. And it wasn't about this quarter. It was about next year. He said the net interest income is a little too optimistic. I don't know how much optimistic means in terms of billions.

2:18Right. At ninety one and a half, he said a little optimistic. So, you know, I took a little bit of haircut there. He talked about expenses, actually, that the street was a little too optimistic there as well. Took a little bit more. They're also not going to be doing aggressive buybacks, which is not particularly new. And so it was an overreaction, but it wasn't a crazy reaction, particularly when you step back and see, wow, where had this stock gone in the two weeks before this? And we knew that there would be a sort of restructuring to Basel Endgame. We still don't know what it is. But there is one thing outstanding that is sort of important, which is for the big trading desks, a Goldman, you know, Bank of America or J.P.

3:00Morgan being probably the biggest, is what will the capital requirements be on that part of their business? That's really important. And that's still very much up in the air. Yeah, Julie. Yeah, it's central because so much of the trading business has been driving revenue for these companies. And it's really challenging for them to find a replacement for that business. And, you know, based on capital requirements, it's going to be tricky for them to really even be able to forecast the net interest income. It makes sense to me that they would be trying to tamp down expectations. This is actually the first bank that's really giving any kind of indication on what 2025 is going to look like.

3:34And I think it makes sense to try to put some conservatism in there, especially if you're a producer. The stock reaction is just a function of expectations being so high, right? The stock has just really been on a tear. Guy, what's your take on the fallout? Well, I mean, first of all, Karen said if you want to hear that call, you can go to the website or you could call Karen's phone and listen to her ringtone. I think you've got to listen to what they're saying. First of all, Jamie Dimon's been saying similar for quite a long time, so I discount that a little bit. But then when you hear Brian Moynihan, who's always effervescent, talk, I don't want to say dour, but somewhat, you know, concern, I think you take that and sort of throw it on everything else we've heard from not only bank CEOs but across a swath of industries.

4:16Look at the BKX, our crack staff back in EC can pull this up. And we just topped out at levels we topped out at in January of 2023. So I think there's a reason technically also to be concerned. And again, when Jamie Dimon, I think it was two and a half, three months ago, said, you know, I think the stock, J.P. Morgan, was trading 202. They weren't going to buy back stock at these levels. The stock was rich. You know, I think he was right in bringing that up. And on a price to tangible book or price to book, historically, it was rich. So I think the banks, I understand why people got enthusiastic, the yield curve re-steepening, but I think it's the wrong environment to think they're off to the races.

4:51Yeah. How do you impute this bank mosaic, Dan, onto the rest of the markets? Yeah. Well, Mel, I was in the same camp as far as Karen was this morning, watching, you know, J.P. Morgan fall off a cliff like that at one point down 7%. I mean, you would think that something is going on, at least in the markets, maybe the economy to see that sort of downward pressure on a market leader like that. And so it just tells me a little bit that investors were looking for an excuse to kind of move out of a very crowded trade. When I think about just what Guy said, I mean, Jamie Dimon has been somewhat subdued on the outlook for, you know, the bank, for the economy, for the idea that rates were going to come down so hard.

5:32So I find it all a bit curious. The one thing I'll just say about some of the commentary in and around trading revenues is like, man, we finally have equity market volatility. We have currency volatility. We have commodity volatility. We have rates volatility. I don't understand how, you know, we're going to see trading down 10 % at Goldman, that sort of thing. So to me, I think it's very curious. And the last thing I'll just say as far as net interest income, I mean, it was supposedly going to be great for these money center banks on the way up with yields. It was supposedly going to be pretty good on the way down.

6:03And it just seems like there's a chorus of folks getting cautious on that line of income. So to me, I do think it's a pretty tricky time to try, you know, picking a bottom in some of these names. Pinto said we're not going to guide down on that yet. So no formal guidance. But you have to wonder when that does come out, what the reaction will, if it trades down again on the same news. Well, we always talk about that phenomenon. Are things trading down on the same news and then some other bank will come out and they'll all trade down again on it. I do want to disagree with Dan on something, just one for the sake of disagreeing with Dan.

6:36But also netting and interest income has been good for the banks. And so, you know, for J.P. Morgan, they have a little bit different mix. Actually, this is a little bit of Bank America's mix probably being better now for them. And then maybe seeing a little less net interest income compression or net interest margin compression. compression. But I would, if you would say to Jamie Dimon, are you optimistic about your business overall going forward? You think he would say? Yes. So that Jacob, J.P. Morgan is very well positioned. We're in this market. We're in that market. You know, we're going to become more efficient.

7:11They did talk a lot about, not a lot, some about productivity enhancements for AI, which will cost them some to get going. But they talked about it in processing, in fraud protection. one other area that I forgot I don't want to split hairs though but I mean saying that your business is good doesn't necessarily mean that the stock or investors are prepared for that, right? Prepared for that sort of forecast What's interesting about, and I agree with Karen I think the more if things start to deteriorate I shouldn't say the more things deteriorate if things start to deteriorate in terms of the economy I think the better prepared and the better suited JP Morgan probably is So I think both those things can be true.

7:53I think he can be concerned about the macro environment and optimistic about his business, the way they've positioned themselves. So that actually the worst things get. I mean, you can make an argument that the better things might be for JPM. Well, how are you feeling about the banks, Julie, at this point, having heard from a lot of them about their businesses? Well, I mean, I still struggle to understand how you differentiate as a bank. It's not a sector that I really find very attractive. What I will say is there is this influx of PE and transactions that has to happen. And we're still in a pretty anemic M &A environment.

8:24What I like are these smaller boutique investment banks because then I don't have to worry so much about trading revenue. I don't have to worry as much about net interest income. It's a cleaner story. So those are the types that I'm more interested in right now. Yeah, we haven't even touched on Ally Financial. And I guess this is a theme that we've been harping on a lot, especially as we have gotten data points from Dollar General and Dollar Tree and those sorts. We know that the low-end consumer, that the lower-income household, Dan, has been having trouble. And this just sort of underscores that point.

8:51And you saw a lot of the operators in this sort of income cohort fall on the back of what Ally Financial said, particularly about auto loans. We saw Affirm. We saw Discovery. We saw Capital One. We saw a lot of them decline on the back of today's comments. Yeah, no doubt. I mean, the knock-on effect to your point about auto loans is you saw AutoNation, you saw Ford, you saw GM getting hit really hard. When we think about some of the past credit cycles, we know that it kind of starts in this subprime area. And you first see some of these defaults, or at least the delinquencies in the auto space.

9:27We've been talking about it, I think, at least through the earnings season over the last two months. What became very apparent, other than some weakness on the high end, a lot of that coming from China. But if you think about the U.S., it's a tale of two economies in a way. And I know we're going to hit that a bit later. But again, to start to see a warning sign like this out of Ally and then see the stock down 17 percent, it is basically round trip the entire move of this past year or so. It's, again, just like JP Morgan at one point down 7 percent. You have to take notice of this sort of price action.

10:00Over the course of the quarter, credit challenges have increased. And what is Phil LeBeau been telling us about the relationship between rates, the Fed sets, versus auto loan rates? Auto loan rates are very sticky. It takes a long time before any Fed rate cuts actually catch up with the rate you would pay on an auto loan. So is this a leading indicator in terms of what it means for credit? And if you throw up an HYG chart, HYG is not worried. I mean, it's 79 and change. I mean, this thing has been flatlining to slightly higher probably for the last seven or eight months. But I guess the question one has to ask again in sort of this conversation is credit the next sort of shoe to drop.

10:38And I think inevitably the answer almost has to be yes. I mean, it's not manifesting itself in terms of spreads or HYG or anything else. But I think it's absolutely out there something to be watched. So for Ally, obviously, of course, fear of charges to come, even if they're not there right now. I think you're looking at different customers at a JP Morgan. However, if an ally really does have trouble and charge-offs go way up, they're all going to get hurt, even if it doesn't affect their own critical. And you've been on the bandwagon of the consumer is going to be really weak and we haven't seen the worst of it, et cetera.

11:13Have we seen it yet, the worst of it? I don't think we've really seen the worst of it, right? We still haven't even really lost any jobs. And that's really when you start to see this cascading effect in terms of credit cycles. The place that I continue to be the most concerned is, you know, we're no longer getting the student loan support that a lot of people had been expecting and counting on. And once that starts to trickle, you really can see an unwinding of the strength of the consumer that we are dependent on in this consumer economy. I just had one thing. It's delinquencies first that we start to see before they actually end up making their way through the, OK, we've got to write it off.

11:46Right. To charge off. Right. OK. It is the last major economic report before next week's Fed meeting. The Consumer Price Index is out tomorrow morning. Let's bring in Michael Schumacher, global head of macro strategy at Wells Fargo Securities. Mike, great to see you. What's your outlook? What's your outlook for the market reaction? Slightly above consensus. So our econ team and Sarah House. So hotter. A little bit, yeah, 0.25. People like to think about that second decimal place right now. I know it's kind of crazy, but still, that's the way it goes. Just a touch above consensus. But I do think that inflation genie is just about back in the bottle.

12:19It's a lot more about the topics you all were just discussing. Consumer, recession, growth. That's where the market focus is now. So 0.25 would make it seem like then 25 basis points would be in the cards for the Fed, much more so than? Than 50. Than 50, yeah. Whereas if it comes out at, say, 0.1, party on. 50 is pretty likely. Right. Jay Powell's all excited at that point, and you've got markets doing, I think, a victory dance. But, yeah, 0.25 would be a little bit challenging. So you think the markets would rally more on a 50 basis point cut? Or do you think that's what you wish for? Exactly.

12:52So is good news good news or is good news bad news? And I'd say in the near term, people do look at the Fed. And markets are taking their cues very much from Fed expectations or other central bank expectations. So it's look at the data, think about the Fed's lens. How does the Fed see it and then react? That's how the markets have been going. So it's a little bit of a Rubik's Cube, right? You get the green side fixed, but then the red side screwed up. And so and I say that in terms of jobs and inflation, because, you know, maybe they figured out the inflation portion, although I'm not convinced.

13:22But on the flip side, as we were just talking about, Julie's concerned about, as am I, it's the employment side that's going to do escape velocity. So they may fix one at the expense of the other. And so where are we on the employment side of things? Because that's the next story, I think. Yeah, the employment indicator has been lagging. So our econ team likes to point to lots of other indicators. So do we. If you look at the quits rate, if you look at jolts, et cetera, et cetera. They've been weakening for quite some time. And we finally had this uptick in unemployment. And then from the clients I talked to, it really caused a big stir when it triggered the SOM rule.

13:54So a bit more than a month ago, people said, oh, wow, it's a great indicator. It's 0.5 now. That's bad. So now people are looking much more tightly, I would say, at the employment indicators than they had been. But you don't get the next report for a while. So tomorrow, yes, all about inflation with this little debate thing, I believe, is tonight as well. So that may get some attention. But I do think you're right, though, Guy, it's going to shift back to the labor market pretty soon. So, Mike, just addressing the politics of it, do you think that plays into the 25 or 50 that the Fed is contemplating?

14:25Whatever. We'll see the data, of course. But is that an element that moves them? Probably not in the near term, though, Karen. I think longer term, if you say, well, what if Donald Trump wins? Forget the debate, but the election. What's the likely configuration of Congress? probably it's unified Republican control. What does that mean? Bigger deficits. The Fed says, oh, lots of deficits, lots of fiscal support. We, the Fed, probably won't need to cut as much. Whereas if Kamala Harris wins, yes, Democrats could win the Senate, but it's a much tougher road to hoe. So I'd say in that case, you get more likely the Fed thinking, hmm, probably not going to get deficits as big.

15:01We then have to cut a bit more. So down the road, it matters quite a bit. The markets may shift their probabilities a little, depending what happens tonight, but not a huge amount, in my opinion. So just looking at the various scenarios and what you think is most likely, what is the best case scenario election-wise for the markets? And I know it's early going. There's a lot of road between now and November. But still, I mean, from clients, what are you hearing? Markets like divided government. And they'd like to see more fiscal restraint. You just haven't had it in Washington in quite some time.

15:31And not even just in the U.S., but in other countries as well. So some lineup where it is divided, that's the best. whether it's Democrat in the White House and Republicans having the Senate or some sort of other scenario. It doesn't matter so much, but divided is what people want to see. All right. Michael, great to see you. Thank you for coming by. Michael Schumacher of Wells Fargo. All right, Julie, what are you thinking for CPI tomorrow? I'm hoping that it's, you know, we get a softer number, but I think I'm pretty concerned about the longer-term outlook. If I think about investor expectations and the setup for 2025, people are expecting double-digit growth in the S &P, and they're expecting, you know, multiple rate cuts.

16:11That's only happened once in 1984, which coincidentally was when my firm was founded. Uh-huh. Interesting. But that is a very tall ask, and that means that expectations are very high, and high expectations lead to broken hearts usually. That sounds like it's needle-pointed on a pillow somewhere in the Beal household. Dan, Ethan, what's your take on our setup into tomorrow's print? Well, I think it's interesting. You know, Guy just mentioned unemployment. If unemployment is going to be going up, then I would expect wage growth is going down. And that's a huge component to inflation. And if you look at some of the inflation break evens, it's suggesting that, you know, we're going to be below 2 percent in the not too distant future.

16:55And I say to myself, OK, well, is this a stagflationary environment? The economy is weakening, too. And so it's a difficult picture. I mean, like if inflation starts to come down faster than expected, it is easy to make the case why the Fed should go on autopilot and start cutting interest rates, I call it 25 basis points at a time. Now, if the economy falls out of bed, then they're going to get a bit more aggressive, not too different than what happened in 2022 when they were raising interest rates to combat inflation. Last thing I'll just say is that China as this engine of growth that no longer exists, if you look at some of the readings that we're getting over there, it's massively deflationary.

17:32So to me, I just really think that, you know, the lack of inflation should be the story going forward. And a soft CPI only makes the case of why the Fed should start cutting sooner than later. I mean, where do we buy a lot of goods from? Where are they manufactured? In China. So deflation over there could potentially be exported here, too. There's a lot of expectation, too, that the housing component will come down because rents have really gone down year on year at this point. The insurance component, though, is not going anywhere. And that's been a huge factor. And we've talked about that for a while.

18:03So, listen, I get it. I mean, people will say they've tamed the inflation dragon the same way they said that in the early 1970s. We shall see. But I'm telling you, if they do go 50, that genie's going to be right out of the bottle. And I think, you know, if you saw Richard Fisher on Squawk Box this morning. Yes. By the way, happy anniversary. It's his 20th anniversary of being a CNBC contributor. It's quite a milestone. And he was quite enthusiastic about that. He should be. But he said for a myriad of different reasons, specifically two, he didn't see 50. One being whether it's political or not, it will be made political, something we've said.

18:36And two, it might send the wrong message to the market in terms of what are they scared of that we're not seeing. Coming up, NVIDIA CEO Jensen Huang set to speak with Goldman Sachs' CEO tomorrow. What investors are hoping to hear and whether it will help NVIDIA shares bounce back. That's next. Plus, Bitcoin's been range bound for the last few months. But could there be a breakout on the horizon? The next move in the crypto space and how the AI surge will impact the Bitcoin mining space. Don't go anywhere. More Fast Money in two.

19:09Welcome back to Fast Money. NVIDIA CEO Jensen Huang on deck to speak at Goldman Sachs' Communicopia conference tomorrow morning. Shares are down almost 25 percent from records. Hit less than three months ago. Gross margins, a major concern for investors after its latest earnings report. Guidance was slightly lower than expected. So what do you want to hear from Huang tomorrow, Dan Nathan? Yeah, I think, listen, first things first, he's going to be in front of a very agreeable audience at a Goldman tech conference. Let's be clear on that. And I think if you think back to August 28th when the company reported, you know, again, big beats, good raises, but just not good enough.

19:45The expectations, whatever Julie just said about expectations and broken hearts. I mean, that's what's happened over the last month and a half or so, down 25 % or so. What I think investors want to hear a little more clarity on is what the delays look like for this Blackwell, this next generation GPU, how long it's going to be, and what is the margin impact going to be? Because if people are basically pulling back from purchases of this hopper because they're waiting for Blackwell, and what does that transition look like from a margin perspective? Earlier this year, investors were very happy to see margins get above 70 % on their way to high 70s.

20:21And if they're working their way back down on a sequential basis, it doesn't leave a lot of room for the stock to appreciate, in my opinion, before we get more clarity on this transition to Blackwell. I mean, his credibility, Jensen Huang's credibility a little bit, is sort of on the line or will be questioned if they can't explain Blackwell. He did say two quarters ago, we're going to have a lot of Blackwell revenue this year. And so there's not a lot left left time to the end of the year to get that black oil revenue if the delays persist. Yes. Although I do think it's about demand, not so much supply.

20:54Right. If they're late. Delayed, not denied. Delayed, not denied. Because there is no other place to go really right now. I mean, AMD somewhat. But to me, I thought I mean, I actually agree with pretty much everything Dan said. I think, though, that NVIDIA, I thought that call from Oracle last night was very, very, very bullish. And yet the reaction to the stock was pretty muted, up only slightly. So it's going to be hard to get excitement, I guess, going again. Yeah, I think it's the same concept of just the level of expectations is so high. And for NVIDIA in particular, the real question is how much can these hyperscalers continue to spend on a prolonged basis?

21:34Right. And so we can talk about the transitions between the different architectures as much as we want. But what we need are these customers to continue to spend at this level. Plus, we need other customers to also be expanding their spend. And that, to me, is still a big question mark. What is the what is the competitive landscape look like one? And what's the growth trajectory for revenue? Because at current valuations, historically, you're a very rich company on price to revenue. So I'm curious to know, like where the sales trajectory is for the next three to five years. Yeah, 1020 a.m. Eastern time is when Huang is scheduled to speak.

22:07There's a lot more Fast Money to come. Here's what's coming up next. The next moves in crypto. Bitcoin looking for a breakout as crypto miners get in on the AI surge. How the latest advancements in tech could impact the entire space. Plus, a biotech block. The House voting to restrict business with Chinese companies. how the move could hit drug prices, and the impact on U.S. relations with Beijing. You're watching Fast Money, live from the Nasdaq market site in Times Square. We're back right after this.

22:48Welcome back to Fast Money. Bitcoin making a comeback after its worst week in more than a year. The cryptocurrency rising for a second day, back near the 58 ,000 level. Separately, Bitcoin miner Core Scientific recently announced a$6.7 billion partnership with NVIDIA-backed cloud startup CoreWeave as it looks to diversify its revenue from crypto to AI. The stock has nearly tripled since relisting in January. CEO Adam Sullivan joins us now. Adam, great to see you. What's your forecast in terms of the revenue breakdown, crypto versus AI? Yeah, looking forward to 2025 and 2026, we are going to become much more predominantly towards HPC revenue.

Read the full transcript

23:22Towards, I'm sorry, what? High-performance computing revenue. Yeah, sorry. Okay, so AI, basically, the layperson. So when we're talking about AI and we're talking about the spend of hyperscalers, et cetera, what are sort of the keywords that you hear that indicate to you that demand for your business will be up? Well, we're seeing the demand today. When we went out and marketed our first set of sites, what we've seen so far is insatiable demand, not only from some of the largest tech companies in the industry, but also from much smaller companies who are looking to enter into the space today, who are looking for smaller allocations from NVIDIA.

23:56And we expect that to be an exceptional demand vector for us over the course of the next few years. Rose like a phoenix, Adam. Congratulations. I'll say this. I think Goldman Sachs had a note in the spring about AI infrastructure and the opportunities there. Speak to that because you're probably at the forefront. Yeah, so Core Scientific, we're a digital infrastructure company at heart, and that enabled us to be the largest Bitcoin mining company for the past three years. And as we look forward to the next three years, We've been looking at how do we continue to develop high performance computing capacity for this major growth vector of GPU cloud.

24:31And that's mainly being driven by AI. And so that's really what we've been capitalizing on first with CoreWeave. And we're excited to be to be working on a number of new clients coming down the pipeline in 2024. So you said that we talked a little bit before you got on about how are you powered, right, which is from the grid. And are you are there concerns about that? How do you feel about, do you want to diversify to more renewable? How do you think about that? Yeah, so we're working with a number of different renewable providers. The one challenge is if you have renewable energy as your sole source of power, you're only up about 30 to 40 percent of the time.

25:07And so you need the utility connection to have that firm up power because data centers require 100 percent uptime. In talking about your customer base kind of expanding, what are the smaller customers starting to use these workloads for? Where is that kind of growth coming from? It's mainly today coming from training. So a lot of smaller companies are looking at attacking very specific training of models. So not these broad-based models that we're seeing today like ChatGPT. These are very specific, whether focused on the medical space or the legal space. And so we expect to see a lot more successful companies coming out of very bespoke industries where they're able to carve out their niche, something completely separate than what the large AI model companies are doing.

25:50Obviously, tonight's a big night for debates, for politics. And President Trump has said that he wants every single Bitcoin mine to be mined in the United States. And I'm wondering, from your perspective, would that change much in reality? And would that actually be good for your business? Well, today, Bitcoin miners represent about 40 percent of them are located in the United States, which is exceptionally high. Yeah. And so as we look forward, you know, forward looking energy policy is good not only for Bitcoin miners, but it's also good for the broad industrial and manufacturing industry as well.

26:19And so we're supportive of folks who are forward thinkers on energy policy to bring more generation back to the United States. Adam, great to see you. Thank you. Adam Sullivan. Pretty cool story. I mean, they do probably half a billion dollars of revenue up to three quarters of a billion. They're going to be, I think, profitable. I'm not good buying the gas, but I'll say this as well. Bernstein just had a note,$17 price target, saying that CORZ is uniquely positioned to take advantage of what's going on. So despite the fact that the stocks had a big move, there's further upside, I believe. Coming up, the crude crush continues.

26:50Our oil prices closing back in on the$65 mark in today's session. What's behind this move? And should investors brace for more energy weakness ahead? But first, Congress is taking on China's biotech industry. We'll take a deep dive into new legislation and the shockwaves of quitsan through the pharma industry. More Fast Money right after this. Missed a moment of fast? Catch us anytime on the go. Follow the Fast Money podcast. We're back right after this.

27:23Welcome back to Fast Money. Stocks closing mixed as investors await tomorrow's inflation data. The Dow falling 92 points. The S &P up about half a percent and the Nasdaq climbing eight-tenths of a percent. Shares of Boot Barn jumping nearly 10 percent to an all-time high after posting strong sales growth this morning. The CEO saying the retailer is benefiting from new store openings in multiple markets. And shares of GameStop sinking after hours separate from earnings. The company filing to sell up to 20 million Class A shares. The stock is down 7 percent. The House of Representatives overwhelmingly passed the Biosecure Act late on Monday, aiming to restrict business with Chinese biotech companies and their subsidiaries in the U.S.

28:01The specific Chinese firms called out in the bill, dropping sharply in today's session. For more on the legislation's potential impact, let's bring in Emily Wilkins. Hi, Emily. Hey, Melissa. Yes, U.S. pharmaceutical companies, they're now on notice that they need to start breaking up with their Chinese counterparts. The measure passed last night would give drug manufacturers up to eight years to remove Chinese companies or companies of other foreign adversaries from their supply chains. If they don't, those products won't be eligible for federal contracts, programs or funding. Now, several so-called companies of concern are listed in the bill.

28:36You had a few of them just up on the screen. Wuxi App Tech, Wuxi Biologics, BGI, MGI and Complete Genomics. Now, the bill comes as the industry is facing a shortage of drugs. But the largest advocacy group for biotech companies, the Biotechnology Innovation Organization, said that the measure provides a reasonable timeline to make this change. The bill is more than one of a dozen set to be voted on by lawmakers this week. It's meant to set limits on Chinese companies in EVs, batteries, drones, ports, elections, among other things. Spoke with House Majority Leader Steve Scalise, and he said that the focus on China and the CCP is partially a response to escalating behavior from China's government.

29:20China's gotten more aggressive, and I think their aggression has really sparked a lot more interest in confronting what they're doing. And so, you know, we surely don't want to be flat-footed, And I think for a few years, America was flat footed to that threat that China poses. One bill is raising concerns among Asian American lawmakers, a measure that would bring back an espionage program in the Department of Justice. And that program was previously criticized for targeting foreigners. Melissa? Emily, how unusual is it for legislation to actually target specific companies? Because it seems like it's been happening specifically with Chinese companies, whether it be TikTok or this bill, which actually names the companies which pharmaceutical companies would have to limit their dealings with.

30:08Melissa, it's really not common. In fact, by naming some of these companies, it does actually risk potentially violating the law. But these companies have been named in here. More could potentially be named. The bill sets up a process by which that could happen. But as you point out, we have seen it a little bit more recently. We see it in this bill. We see it in TikTok. And when it comes particularly to the pharmaceutical bill, I should note that beyond having strong bipartisan support in the House, it also has pretty strong support in the Senate. So this is one of those bills could wind up becoming law before the end of the year.

30:42Emily, thank you. Emily Wilkins. Now, what is interesting, because many people won't know about Wu Xi and the role it plays in the pharmaceutical industry, it has played a role in one out of every four drugs used in the United States. So it's been a contract player in this industry for a very long time. And it makes actually the critical components for a lot of other drugs, leukemia treatments like Imbruvica, et cetera, that are currently on the market. So what do you think of that time frame of eight years? Is that enough time? It seems like a long time, but I don't. It does seem like a long.

31:13It seems like enough time. But the question is, what's the reasoning behind it? And do we set up a framework where we are just going to be, dare I say, xenophobic? Right. You know, protectionism to an extreme. are we thinking about this in the right framework? Instead of naming specific companies and wanting to pick out winners and losers in the market, whether they be in the China market or elsewhere, is that what we should be doing as a country, as a capitalistic country? I think that's the overarching theme. And a lot of these issues came to light during COVID. A lot of people brought these things up, were dependent upon, blah, blah.

31:46So there's no doubt that it's a great conversation. It's one worthy of having. But the bigger picture is, what does it mean? Again, it's very inflationary, I think. And then one has to wonder what happens sort of on the quid pro quo side of things. What happens on the retaliation front, which is something I've been concerned about for a while. Unfounded, by the way, because nothing's happened, but it doesn't mean it won't. For smaller biotech companies, this will have much more of an impact than for larger companies with deeper pockets. I mean, a lot of VCs are out there and they're saying, you know, a lot of their portfolio biotech companies, they are dealing with this issue as well because they use these services.

32:21They outsource the research and development part of it to these Chinese companies. That's why the cycles are so long, right? That's why eight years feels like a really long time. But when you're developing some of these products, that is literally how long it takes for them to come to market. And, you know, I think we don't we underestimate how much collaboration there is. But so much of the outsourcing that happens is particularly on the genetic front. And I can understand the government's wanting to keep more of this IP internally. But we are not set up for that. The way our biotech is set up, it's not set up to do it that way.

32:51Yeah. Like a lot of other things, when you bring processes back to the United States, what happens? It gets more expensive. Exactly. Coming up, crude oil prices taking a hit where the commodity is heading next and what the technicals are saying about the weakness. And live from CNBC and Boardroom's Game Plan Conference in L.A., WNBA star Cameron Brink. She'll join us next to talk basketball, brands, partnerships, and much more. That interview when Fast Money returns.

33:24Welcome back to Fast Money. Crude oil continuing its decline. WTI down another 4 % today, hitting levels not seen since December 2021. It's now down nearly 25 % over the past year and taking energy stocks down with it. It is the only S &P sector that is down over the last 12 months. Dan. Yeah, you know, it's interesting. You have crude oil at 52-week lows. You have Yields at 52-week lows. Sorry about that. And you have the dollar at 52-week lows. But you only have the S &P 500 down 3 % from its highs. So something's got to give right here. I suspect you see a bounce in the dollar in not-so-distant future.

34:00The C in clam is either Conoco or Chevron or one of them. I mean, the clam outside of the clam XC, so lamb. Lamb is doing really well. Lamb is doing fine. It's been a tough slog in the underlying commodity. and now the equity is starting to roll over. I mean, very quietly, OIH is down about 265 or so, Exxon down to 110. I get it. I understand what's going on here. But I look at a name like Occidental Petroleum, OXY, which is trading$51 and change, a name that Warren Buffett probably owns 30 percent of. He clearly sees something, whether it's in the space or that stock specifically. That stock he's going to wind up buying.

34:37So if you're looking for sort of a binary play here, I think at$51, Oxy on the back of Berkshire Hathaway finally sort of pulling the trigger is probably your best bet. Coming up from basketball to brand, WNBA star Cameron Brink will join us from CNBC and Boardroom's Game Plan Conference in L.A. How she's winning on and off the court. That interview is next. More Fast Money in two.

35:07Welcome back to Fast Money, CNBC and Boardroom's Game Plan Conference. taking place today in Los Angeles, bringing together some of sports' top athletes, leaders, and innovators to tackle topics like streaming, the future of sports betting, and beyond. The WNBA is one of the fastest-growing leagues in the world, thanks in part to a massive influx of rookie star power this year. Our Julia Borson is live with one of the league's brightest young stars, Los Angeles Sparks forward Cameron Brink. Julia, take it away. Melissa, thanks so much. And Cameron, thanks so much for joining us. You know, you were number two overall WNBA draft pick and you're coming off record ratings for the women's NCAA season.

35:46What do you think is driving this interest, not just in the WNBA, which also had a big surge in ratings, but just women's sports in general? Yeah, I mean, that's such a great question. I think it's really been social media and we've really been able to brand ourselves without, you know, brands having to partner with us. We're able to put our stories out there. But I think I always say this, but we have to look to the women before us that have kind of been building this path for us. So, you know, without Cheryl Swoops and the Lisa Leslie's of the world, so many others, we wouldn't be where we are today.

36:17Now, you mentioned social media. You've been building your audience on social media since you were in high school. And that has led you to have an amazing assortment of brand partners, including New Balance. How do you think about finding the brand partners that make the most sense for you? My parents have always said this, but if you just act authentically in the world, people will come to you. So I feel like I've done a good job of just authentically being myself. And brands like New Balance came to me and gave me the best opportunity to work with them. And I align with everything they align with, and they're a great company.

36:50And then I get to work with other brands like Skims before this season and LegalZoom. I actually did a shoot with them right after I got injured, but they've all been so accommodating and so helpful even through, you know, rehab and everything. So it's been really great. Yeah, and through your rehab, you've been not just at the games but continuing to communicate with your fans on social media. What do you think the advantages of that? Do you think you're bringing in new fans who maybe didn't watch the WNBA before? I hope so. I think, you know, sometimes I get to walk in, you know, for games, pregame for the tunnel walks, and I'm able to put on a cute outfit and kind of connect to people that are more into fashion.

37:26Like, I love makeup. I hold a girls basketball camp so hopefully I connect with young girls. So even though I've had a small setback, I feel like social media has been a great platform for me to continue to show the world that I'm just still going at things and still being a business woman. Well, Karen Feinerman, who's an investor in the WNBA, has a question for you. Karen? Yeah, hi, Karen. Thanks so much for being on. I'm a diehard New York Liberty fan because I live here, but I'm also a Stanford women's basketball fan. So, therefore, a big fan of yours. I wonder if you could tell us about how you found the transition from college basketball to a sort of really energized WNBA.

38:06And I know, obviously, you were injured and hopefully ready for next year. How was that transition before that? To be frank, it's really hard. I think going straight from the college season to the draft, which is really tiresome but amazing. and then I went into an Olympic trial for three on three, and then the season starts in training camp. So it's a lot, and I think a lot is demanded of our bodies. And when I got to LA, it was like, I was on this crazy tour of going to a Dodgers games and appearances, so I was doing a lot. And I definitely think fatigue plays into it. So once rookies can kind of get past that first year of just really difficult mileage on their bodies, I feel like the next year will be a lot easier for us.

38:52But my best advice to, you know, rookies coming in is just take care of your body and your mental and, you know, because it's really tiresome. Well, we're very grateful to have you here in L.A. And I've taken my sons to Sparks teams. And it's just amazing to me how diverse the audience is at these teams. It's not just young women, but also young men at these games. But Cameron, I hope you'll be back and talk to us more about your journey. We really appreciate you joining us here on Fast Money. Yes. Thank you so much for having me. I'll send it back to you guys. All right, Julia, thanks. And, of course, our thanks to Cam Brink.

39:22So, I mean, this has been an amazing trajectory for the WNBA in general. Yes. I mean, so many great stars. She was one of them, obviously, Caitlin Clark and Cameron Brink. But it's just so it's starting to sort of get sort of escape velocity with now you're getting these giant media deals. And it was sort of a chicken and egg as well. Throw a bunch of metaphors in there. But now it's all sort of coming together. Really exciting. And the level of play is extraordinary. Even Melissa came to it. And I had an amazing time. It was so exciting. It was such a great experience. Yeah, I think the level of play is exceptional.

39:55And I think even like building up all the momentum of the Olympics where people are suddenly so much more enthusiastic about women's sports. It's pretty exciting to see. Cameron Brink's godfather, little known fact, is Del Curry. Now you'd be like, well, who's Del Curry? Who's Del Curry? He's the father of Steph Curry. Really? I mean, so it's pretty cool, right? And you're spot on in terms of the level of play is off the charts to the point where I'll absolutely watch a WNBA game before an NBA game for the level of play. So good for them. Up next, final trades.

40:42Welcome back to Fast Money. Take a look at our chart of the day. The stark divergence between shares of Dollar General and Ferrari over the past couple of years may highlight the big difference between Main Street and Wall Street, while the two largely tracked until the start of last year. Since then, it's been off to the races, so to speak, for the luxury car maker, while the dollar store is down sharply. Dan, what does this tell you? Yeah, it goes back to economies. But this is also global, too. I think the dollar gen really speaks to a lower-ended consumer here, sadly. And then that global luxury consumer is alive and well.

41:18Yeah. Julie? I think it's the Lewis Hamilton effect, personally. That's an F1 thing, right? I guess so. By the way, Cameron Brink would just smoke Dan Nathan in basketball. It would be embarrassing. She's probably like two heads taller than Dan. I would imagine. I mean, Dan's a tall guy, but she's extremely. He would be trash talking her and she would just be, you know. Dish it back, probably. Right? Yeah, probably. Would you rather? Oh, go ahead. Oh, did you think I was going to say Cameron Brink or Dan? Well, it's Cameron Brink all day. No, Dollar General or Ferrari. Ferrari. Oh, come on. That's a yes.

42:00Ferrari. Race. Race above DG. Time for the final trade. Let's go around the horn. Dan Nathan. Yeah, I got to say, shout out to CNBC and Boardroom. This event is absolutely amazing out here. Lots of optimism about the future of sport, culture and everything above. UUP. I think the dollar bounces here. Karen. Yeah, so we're looking at this little bit of a bank shakeout here. I do like Citi Bank, but I think you can wait a day or two. I'm long. Julie Beal. Yes, I'm also avoiding the banks generally, but investment banks like Mollis, I'm interested. Fun fun to have you on set, by the way. I know. Back tomorrow, Julie Beal.

42:37You know, Melms was saying, and I don't know if you have anything to add to this, but you were surprised at how poorly the Jets played on defense last night, given that they came in this season, this vaunted top five defense. and you're saying, how do you give up eight consecutive possessions of points? Inexplicable. Inexplicable. So is the move in Gilead, GILT, Melms. Thanks for watching Fast. See you back here tomorrow at 5 for more Fast Money. Mad Money with Jim Kramer starts right now.

43:07All opinions expressed by the Fast Money participants are solely their opinions and do not reflect the opinions of CNBC, NBC Universal, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet, or another medium. You should not treat any opinion expressed on this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion. Such opinions are based upon information the Fast Money participants consider reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such.

43:41To view the full Fast Money Disclaimer, please visit cnbc.com forward slash Fast Money Disclaimer.

From the publisher

Big banks in the red, with JPMorgan leading the drop, as top execs lower expectations for results. How the financial warnings could be a sign for broader pain ahead. Plus Lawmwakers passing the Biosecure Act… targeting Chinese firms. What it could mean for drug prices, and the impact on U.S.-China relations.

 

Fast Money Disclaimer


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from CNBC's "Fast Money"

All 871 episodes
Banks Get Hit… Plus Lawmakers Target Chinese Biotechs 9/10/24CNBC's "Fast Money" · 44 min
Listen in VO